Dear Member

Welcome to the latest issue of our newsletter which highlights some of the resources and events forming part of our programme of outreach to the infection control community to raise awareness of the status of the scientific evdience supporting the use of copper in hospitals.

In this issue:

New Publication - The Scientific Evidence

Forthcoming Events

Multimedia Resources

Copper Development Association has prepared a new 4-page publication giving an update on the status of the scientific evidence on antimicrobial copper. This includes the Selly Oak (UK), Asklepios (Germany) and 3-centre US clinical trials, the EPA registration and practical considerations for incorporating copper into the clinical environment. Key references are cited.

The publication can be downloaded here.

Forthcoming Events

Copper Development Association will be participating at a number of events to help raise awareness of the latest antimicrobial copper research findings. These events provide an opportunity for any members of the Interest Group to visit for one-to-one discussion.

Following the extremely successful 'Copper and Public Health' Conference in Athens last November, the presentations are now available online or on DVD. Session II has the science:

• Prof Bill Keevil - laboratory findings.
• Dr Harold Michels - the US EPA registration of copper as an antimicrobial material.
• Prof Tom Elliott - the Selly Oak trial results.

CDA has created a new webpage with images of installed and prototyped products from the Selly Oak trial with links to suppliers.

Dr Mike Schmidt, one of the researchers involved in the US clinical trials and another Athens speaker, was interviewed for NPR's science talkshow 'Science Friday'.